Back to Search
DAVID ETTINGER, M.D.
M.D.
Medical Oncology Physician
NPI: 1720016777Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
D17207(MD)
Research & Publications (20)
Evaluation of the relative importance of chemotherapeutic and antiemetic efficacy in various oncologic settings.
PMID 18762991·Support Care Cancer·2009
8-other
Amrubicin for the treatment of small cell lung cancer: does effectiveness cross the Pacific?
PMID 17410034·J Thorac Oncol·2007
6-review
Update: NCCN small cell and non-small cell lung cancer Clinical Practice Guidelines.
PMID 16280105·J Natl Compr Canc Netw·2005
8-other
An overview of Eastern Cooperative Oncology Group stage III non-small cell lung cancer studies.
PMID 16015545·Semin Oncol·2005
8-other
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
PMID 15939930·J Clin Oncol·2005
3-trial
Non-small cell lung cancer treatment-related bone marrow toxicities.
PMID 16015540·Semin Oncol·2005
6-review
Pemetrexed (Alimta): a new antifolate for non-small-cell lung cancer.
PMID 14720351·Clin Lung Cancer·2002
8-other
Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
PMID 12234701·Lung Cancer·2002
3-trial
New drugs for chemotherapy-naive patients with extensive-disease small cell lung cancer.
PMID 11479894·Semin Oncol·2001
6-review
Antiemesis. Clinical Practice Guidelines in Oncology.
PMID 19460282·J Natl Compr Canc Netw·2009
6-review
RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
PMID 19096311·J Thorac Oncol·2009
3-trial
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignancies.
PMID 19182243·Oncologist·2009
3-trial
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors.
PMID 18379785·Cancer Chemother Pharmacol·2008
3-trial
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.
PMID 17509259·J Natl Compr Canc Netw·2007
8-other
Non-small cell lung cancer: adjuvant and neo-adjuvant chemotherapy.
PMID 17539833·Respirology·2007
6-review
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
PMID 17624289·J Natl Compr Canc Netw·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 10755 FALLS RD
LUTHERVILLE, MD 21093 - Phone
- (410) 583-2970
Quick Facts
- NPI
- 1720016777
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile